Drug Database
Back to search

Germany· DE-A57-36458884dba78034

Cefpodoxim Ratiopharm

A cefpodoxime product containing cefpodoxime, registered in Germany by Ratiopharm Gmbh. The same ATC class is registered in 6 of our 19 countries.

ATC J01DD13

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedCefpodoxim RatiopharmATCJ01DD13REGISTER NO.DE-A57-36458884dba780…PACKS LISTED0CHECKEDAugust 5, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cefpodoximeAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cefpodoxime is registered in 6 of 19 countries.

Countries holding a registration under ATC J01DD13 (cefpodoxime), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 4 of them publish a price we can compare per daily dose
Search cefpodoxime products by name

Cefpodoxime · ATC J01DD13

6 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cefpodoxime costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $3.33 in Italy to $8.39 in Switzerland — a ×2.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cefpodoxime · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$8.39
  • IT Italy$3.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Cefpodoxime
Manufacturer
Ratiopharm Gmbh
Country
Germany (DE)
ATC code
J01DD13
ATC class
Cefpodoxime
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
August 5, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

113 interactions on record for cefpodoxime.

Graded by severity as the source publishes them — 45 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cefpodoxime against other medicinesHow interaction checks work

Cefpodoxime · interactions on record

113 records

  • 45 moderate
  • 68 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefpodoxime in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefpodoxime products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Biocef
  • Bulgaria · Ximebac, Фоксеро
  • Czechia · Forexo
  • France · Cefpodoxime Biogaran, Cefpodoxime Cristers Pharma
  • United Kingdom (Northern Ireland) · Cefpodoxime Proxetil, Cefpodoxime Proxetil Sandoz
  • Croatia · Rexocef
  • Italy · Cefpodoxima Mylan, Cefpodoxima Sandoz
  • Portugal · Cefpodoxima Alkaloid
  • Romania · Forexo
  • Slovenia · Trexodo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/da1787cb-184f-4bbf-af12-8a7b319cc255
GET /v1/drugs/da1787cb-184f-4bbf-af12-8a7b319cc255?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Cefpodoxime",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}
API referenceMCP serverPlans

See everything about cefpodoxime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console